Chemical Computing Group acquires Discngine

New York, NY — Chemical Computing Group ULC (“CCG”), an operating company of Altaris, LLC (collectively with its affiliates, “Altaris”), announced today that it has completed the acquisition of Discngine SAS (“Discngine”). Discngine provides software solutions and IT services for life sciences research and drug discovery. Discngine is headquartered in Paris, France.

CCG is a leading provider of molecular modeling and drug discovery software. CCG’s software platform streamlines drug discovery processes by enabling researchers to visualize and predict molecular properties and interactions in silico. CCG is headquartered in Montreal, Canada.

The addition of Discngine bolsters CCG’s technical science capabilities and creates meaningful value and synergies for CCG, Discngine and their combined customer base. Following the acquisition, Discngine will operate as a subsidiary of CCG.

CCG was advised by Fasken Martineau DuMoulin LLP and Bersay. Lamartine Law Office acted as legal counsel to Discngine.

About Altaris

Altaris is a healthcare investment firm with an exclusive focus on building companies that deliver value to the healthcare system through innovation and efficiency. Since inception in 2003, Altaris has invested in 49 healthcare companies which have generated significant value appreciation for investors. Altaris is headquartered in New York City and manages approximately $5.0 billion of equity capital. For more information, please visit

About Chemical Computing Group

Chemical Computing Group ULC is a leading provider of molecular modeling and drug discovery software. CCG’s software platform features the Molecular Operating Environment (MOE), which is a single package for visualization, molecular modeling, computer-aided molecular design (CAMD), cheminformatics, bioinformatics and methodology development. CCG also produces PSILO, a protein structure repository. For additional information, please visit:

About Discngine

Discngine SAS is a software and IT services company for life sciences research organizations, including pharma and biotech companies. Discngine’s expertise in cheminformatics, structural bioinformatics, laboratory informatics and knowledge management ranges from custom development and SaaS solutions to software components and third-party product integration. Discngine’s main software platform is 3decision. For additional information, please visit: